Multisite experience of the safety, detection rate and diagnostic performance of fluciclovine (18F) positron emission tomography/computerized tomography imaging in the staging of biochemically recurrent prostate cancer. Bach-Gansmo, T., Nanni, C., Nieh, P. T., Zanoni, L., Bogsrud, T., Sletten, H., Korsan, K. A., Kieboom, J., Tade, F. I., Odewole, O., Chau, A., Ward, P., Goodman, M. M., Fanti, S., Schuster, D. M., & Willoch, F. Journal of Urology, 197(3):676–683, 2017.
doi  bibtex   
@article{bach-gansmo_multisite_2017,
	Author = {Bach-Gansmo, Tore and Nanni, Cristina and Nieh, Peter T. and Zanoni, Lucia and Bogsrud, Trond and Sletten, Heidi and Korsan, Katrine Andersen and Kieboom, Jasper and Tade, Funmilayo I. and Odewole, Oluwaseun and Chau, Albert and Ward, Penelope and Goodman, Mark M. and Fanti, Stefano and Schuster, David M. and Willoch, Frode},
	Doi = {10.1016/j.juro.2016.09.117},
	Journal = {Journal of Urology},
	Number = {3},
	Pages = {676--683},
	Title = {Multisite experience of the safety, detection rate and diagnostic performance of fluciclovine (18F) positron emission tomography/computerized tomography imaging in the staging of biochemically recurrent prostate cancer},
	Volume = {197},
	Year = {2017},
	Bdsk-Url-1 = {https://doi.org/10.1016/j.juro.2016.09.117}}

Downloads: 0